In Depth 24 Apr 2024
Overcoming toxicities: are IL-2 smart cytokines the next big thing?
A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it.
Clinical trial
- Latest Posts
Complex innovative designs: tackling rare disease clinical trial challenges
Unlock the power of complex innovative designs to tackle rare disease clinical trial challenges efficiently.
Best in Biotech 16 Apr 2024
Seven biotech companies climbing their way up in Colorado
We take a look at seven biotechs in Colorado that have secured funding in recent years, to make headway with their pipeline candidates.
In Depth 15 Apr 2024
Does the FDA need to tighten its grip on drug trials in the U.S.?
Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process.
Best in Biotech 11 Apr 2024
Seven companies leading the mRNA revolution in biotechnology
Here are seven mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials.
Expert Advice 5 Apr 2024
How to build a career as an investigator at the FDA?
Discover the role and implications of an FDA investigator, a career of high responsibility and challenges, from qualifications to application.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 28 Mar 2024
Are these T cell receptor (TCR) therapy companies on your radar?
As biotechs step up in the TCR therapy space, here are seven companies with promising candidates in the clinic.
In Depth 27 Mar 2024
Are new treatments for multiple sclerosis on the horizon?
As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise.
Best in Biotech 21 Mar 2024
Eight CAR-T cell therapy companies you should know about
Discover eight promising biotech companies that are advancing their CAR T cell therapy candidates in the clinic.
In Depth 4 Mar 2024
ALS: how close are we to a cure?
Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.
Podcast 23 Feb 2024
Precision neuromedicine: A new dawn for neurological disorders
This week on our podcast, explore how precision neuromedicine is reshaping neurological care with Rapport Therapeutics.
In Depth 21 Feb 2024
Cytokine release syndrome: how pharma is tackling a 21st century disease
Explore the frontier of biotech’s battle against cytokine release syndrome (CRS), from historical setbacks to cutting-edge solutions.
ADVERTISEMENT
